ADMA Biologics ADMA Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from ADMA Biologics’s reported figures.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ADMA Biologics's enterprise value?
- ADMA Biologics (ADMA) reported enterprise value of $2.21B in Q1 2026.
- How has ADMA Biologics's enterprise value changed year-over-year?
- ADMA Biologics's enterprise value decreased by 52.5% year-over-year, from $4.65B to $2.21B.
- What is the long-term trend for ADMA Biologics's enterprise value?
- Over 5 years (2020 to 2025), ADMA Biologics's enterprise value has grown at a 59.2% compound annual growth rate (CAGR), from $423.58M to $4.33B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.